OTC Pharmaceuticals - Benelux | Statista Market Forecast

The OTC Pharmaceuticals market in Benelux is projected to generate a revenue of US$2.30bn in 2024.
With an expected annual growth rate of 3.24% (CAGR 2024-2029), the market is poised for steady expansion.
Among the various markets, Cold & Cough Remedies stands out as the largest, with a market volume of US$482.60m in 2024.
When compared to other countries globally, the United States leads the pack in terms of revenue generation, with a staggering US$41.24bn in 2024.
In relation to the total population, per person revenues amount to US$76.45 in 2024.
As for the online sales channel, it is expected to contribute 22.75% of the total revenue in the OTC Pharmaceuticals market by 2024.
Benelux has seen a rise in demand for natural and herbal OTC pharmaceuticals, driven by a growing preference for holistic health remedies.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Benelux is experiencing steady growth due to customer preferences for self-medication, increasing healthcare costs, and the availability of a wide range of OTC products.

Customer preferences: Customers in Benelux are increasingly turning to OTC Pharmaceuticals for self-medication. This trend is driven by the convenience and accessibility of OTC products, as well as the desire for immediate relief from common ailments. Customers appreciate the ability to treat minor health conditions without the need for a prescription or a visit to the doctor, saving both time and money. In addition, the growing popularity of preventive healthcare has also contributed to the demand for OTC Pharmaceuticals, as customers seek to maintain their overall well-being.

Trends in the market: The OTC Pharmaceuticals market in Benelux is witnessing several key trends. Firstly, there is a growing demand for natural and herbal remedies, as customers increasingly seek alternatives to traditional pharmaceutical products. This trend is driven by a desire for more holistic and sustainable healthcare options. Secondly, there is an increasing focus on personalized medicine, with customers looking for OTC products that are tailored to their specific needs and preferences. This trend is supported by advancements in technology and the availability of personalized health information. Lastly, there is a rising demand for OTC products targeting specific demographics, such as children, women, and the elderly. This trend is driven by the unique healthcare needs of these groups and the desire for specialized products.

Local special circumstances: The OTC Pharmaceuticals market in Benelux is influenced by several local special circumstances. Firstly, the region has a well-developed healthcare system and a high level of healthcare expenditure. This provides a strong foundation for the OTC market, as customers have access to quality healthcare services and are willing to spend on self-medication. Secondly, the region has a high level of health literacy, with customers being well-informed about healthcare and actively seeking information on OTC products. This creates a favorable environment for the growth of the OTC Pharmaceuticals market. Lastly, the region has a strong regulatory framework for OTC products, ensuring their safety and efficacy. This instills confidence in customers and encourages them to use OTC products.

Underlying macroeconomic factors: The growth of the OTC Pharmaceuticals market in Benelux is supported by several underlying macroeconomic factors. Firstly, the region has a stable and prosperous economy, with high levels of disposable income. This enables customers to afford OTC products and drives demand. Secondly, the region has an aging population, which is more prone to health issues and requires regular medication. This demographic trend contributes to the demand for OTC Pharmaceuticals. Lastly, the region has a strong pharmaceutical industry, with several local and international companies operating in the market. This ensures a steady supply of OTC products and promotes competition, leading to innovation and product development.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.